FindTrial
Sign In

Study of jatharagni in hypertensive patients

Evaluation of status of jatharagni in essential hypertension-case control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041720
Enrollment
362
Registered
2022-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Parul Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1)Primary Hypertensive Patients Minimum 1 Year. (2)Patients Irrespective Of Patients Irrespective Of Their Gender, Occupation, Religion, Socio-economic Status Will Be Selected.

Exclusion criteria

Exclusion criteria: Patients of Hormonal Disorder, Cushingââ?¬•s Syndrome, Chronââ?¬•s syndrome, Pheochromocytoma Due To Secondary Hypertension.

Design outcomes

Primary

MeasureTime frame
To Assess the jatharagni in essential hypertensionTimepoint: 1 day—

Secondary

MeasureTime frame
Hypertension is considered to be silent killer. Hypertension has become global burden; it is due to faulty & stressful lifestyle. Due to changes in lifestyle, problems related to digestion are increasing, hampered function of jatharagni leads to many diseases. so, there is attempt to check status of Jatharagni in essential hypertension. Timepoint: 1 day—

Countries

India

Contacts

Public ContactDrRohitkumar Arvindbhai Baldha

Parul Institute of ayurveda

dr.spnikhate@gmail.com9521166422

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026